跳至主要内容
临床试验/ACTRN12610000455066
ACTRN12610000455066尚未招募未知

Randomised Controlled Trial of Cognitive Behavioural Therapy for the Treatment of Anxiety and Depression in Parkinson’s Disease

Curtin University of Technology0 个研究点目标入组 126 人开始时间: 2010年6月3日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
126

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1) At least 6-months post-diagnosis of Parkinson’s Disease
  • 2) Stable use of antiparkinsonism medications
  • 3) Meet the criteria for depression and/or any anxiety disorder as outlined in the American Psychiatric Association's
  • Diagnostic and Statistical Manual of Mental Disorders Version 4; Text-Revision (DSM-IV-TR)
  • 4) If on antidepressant medication, this must have been stabilised (same medication and dosage) for at least 3 months prior to baseline assessment
  • 5) If on antidepressant medication, agreement to remain on the same medication and dosage over the duration of the study where possible
  • 6) Agreement to not pursue other psychological treatments during the course of the study and over the 6-month follow-up period.

排除标准

  • 1) Undergoing concurrent psychological treatment
  • 2) Individuals who exhibit cognitive impairment (defined as a Mini Mental State Examination score < 24)
  • 3) Meet DSM-IV-TR criteria for Psychosis
  • 4) Show high suicide risk (defined as meeting the diagnosis for Current Suicidality as assessed by the Mini Neuropsychiatric Interview; MINI)

研究者

发起方
Curtin University of Technology

相似试验